hemophagocytic syndrome
Showing 1 - 7 of 7
Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)
Recruiting
- Hemophagocytic Syndrome
- cyclophosphamide
- +3 more
-
Chongqing, ChinaThe Second affiliated Hosptial of Chongqing medical University
Jun 28, 2023
Prospective Validation of the OHI Index
Recruiting
- HLH
- +4 more
-
Kfar Saba, Israel
- +1 more
May 21, 2023
Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- iCaspase9-transduced T cells
- AP1903
-
Houston, Texas
- +1 more
Jul 22, 2022
Granulomatosis With Polyangiitis, Hemophagocytic Syndrome Trial in Changchun (Meperizumab injection, NUCALA®)
Not yet recruiting
- Granulomatosis With Polyangiitis
- Hemophagocytic Syndrome
- Meperizumab injection
- NUCALA®
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Apr 28, 2022
Children and Adult Hemophagocytic Syndrome (HLHa)
Completed
- Hemophagocytic Syndrome
- Identification of biological markers
-
Paris, FranceClinical Research Unit
Nov 19, 2021
Hemophagocytic Syndrome, T/NK-Cell Lymphoma Trial in Zhengzhou (Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine,
Recruiting
- Hemophagocytic Syndrome
- T/NK-Cell Lymphoma
- Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
-
Zhengzhou, Henan, ChinaOncology Department of The First Affiliated Hospital of Zhengzho
Aug 3, 2021
Hemophagocytic Syndrome Trial in Beijing (PEG-rhG-CSF, rhG-CSF)
Not yet recruiting
- Hemophagocytic Syndrome
-
Beijing, ChinaBeijing Friendship Hospital
Aug 3, 2020